KospicyKorean filings in English
Filings / POLARIS UNO, Inc.

Beneficial Ownership Report (5%) — Standard Form

POLARIS UNO, Inc. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 114630 Filed 2026-11-09Korean original on DART

English form view 55% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

(주)폴라리스우노

0000

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-06
To: Korea ExchangeReport reference date:2026-11-06
Reporting person:(주)루멘스바이오스
Summary
Issuer name(주)폴라리스우노Relationship to Issuer-
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report7,900,00034.00
Current Report7,900,00034.00
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report7,900,00034.00
Current Report7,900,00034.00
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report주식 및 전환사채 양수도 계약의 변경[거래종결일 및 대금지급방법 변경]
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name(주)폴라리스우노Company code114630
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)17,235,248

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeSeparate
Reporting person typeDomestic corporationNationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean(주)루멘스바이오스Chinese characters (English)LUMENS BIOS CO.,LTD.
Address (Head Office) [Town/District Level Only]경기도 용인시 기흥구Date of Birth or Business Registration No., etc.135-81-19745
Occupation (business)LED(발광다이오드), LED조명 등의 제조 및 판매Relationship to Issuer-
Business contact and person in chargeAffiliated company(주)루멘스바이오스Department경영본부
PositionExecutive Vice PresidentPhone Number031-80***
Name서효정Fax number031-80***
Email address**lumens.co.kr

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)156,110,248,230Total Liabilities50,173,363,972
Total Equity105,936,884,258Paid-in Capital24,051,534,500
Representative (representative or managing partner)양 영 학
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)(주)넥스턴앤롤코리아Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)27.36

1) 상기 재무자료는 2025-12-31 연결재무제표기준으로 작성되었습니다.2) 상기 최대주주 지분율은 보고서작성기준일 현재 발행주식총수 25,837,248주 중 7,069,032주 기준으로 작성되었습니다.【보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)340,909,640,792Total Liabilities118,396,989,737
Total Equity222,512,651,055Paid-in Capital37,290,585,000
Representative (representative or managing partner)이 주 한
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)㈜로아앤코홀딩스Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)17.99

1) 상기 재무자료는 2025-12-31 연결재무제표기준으로 작성되었습니다.2) 상기 최대주주의 지분율은 2025년 사업보고서 기준으로 작성되었습니다.

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
---------
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026.10.21(주)루멘스바이오스07,900,00034.001,900,00011.0217,235,248
This Report2026.11.06(주)루멘스바이오스07,900,00034.001,900,00011.0217,235,248
Change00.0000.000

4. Purpose of holding

Impact on management control

| 본인은 거래종결 및 전환사채 전환으로 회사의 최대주주 지위를 확보한 이후, 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호의 사항에 대하여 회사의 최대주주로서 영향력을 행사할 계획입니다. 현재 아래 각 호의 사항에 대한 세부 계획은 미정이나, 회사의 최대주주로서 회사의 업무집행과 관련한 각 호의 사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 사항을 결정할 예정입니다. |
[자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호(아래 1~10호)]
1. 임원의 선임·해임 또는 직무의 정지
2. 이사회 등 회사의 기관과 관련된 정관의 변경
3. 회사의 자본금의 변경
4. 삭제.
5. 회사의 합병, 분할과 분할합병
6. 주식의 포괄적 교환과 이전
7. 영업전부의 양수·양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수·양도
8. 자산 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분
9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익 전부를 같이하는 계약, 그 밖에 이에 준하는 계약의 체결, 변경 또는 해약
10. 회사의 해산
- 본인은 2026-10-21 ㈜폴라리스세원 및 폴라리스투자조합과 주식, 전환사채 및 경영권 양수도 계약을 체결하고 2026-11-06 변경합의서를 체결하였으며, 거래종결일(2026-12-07 예정)에 대상 주식 및 전환사채를 인도받은 후 전환사채를 지체 없이 전환하여 회사의 최대주주 지위를 확보할 예정입니다. 거래종결 이후 상기 보유목적 개요의 각 호 사항에 대하여 회사의 최대주주로서 영향력을 행사할 예정이며, 회사의 업무집행과 관련하여 상기 각 호의 사항이 발생할 경우 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다. |
|---|

5. Reason for change

Method of change-
Reason for change-
Reason for Change보유주식등에 관한 주요계약(주식, 전환사채 및 경영권 양수도 계약)의 내용 변경 (2026. 11. 6. 변경합의서 체결: 거래종결일 2026. 12. 11. → 2026. 12. 7., 매매대금 전액 현금 지급으로 변경)

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person㈜루멘스바이오스135-81-197451,900,000---6,000,000----7,900,00034.00
Specially Related Party-------------
-------------
Aa1a2BCDEFG
H

※ 전환사채권: ㈜폴라리스우노 제4회 무기명식 이권부 무보증 사모 전환사채 권면총액 15,000,000,000원 ÷ 전환가액 2,500원 = 6,000,000주

Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
17,235,2486,000,00034.0011.02

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person㈜루멘스바이오스135-81-19745-7,900,000-----7,900,00034.00
Specially Related Party-----------
-----------
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
Yes

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ㈜루멘스바이오스 | Self | 135-81-19745 | Voting Shares | 1,900,000 | ㈜폴라리스 |
세원 | 주식 및
경영권
양수도 계약 | 2026.11.06 | 2026.10.21~
2026.12.07 | 8.18 | 주1,2) |
| 2 | ㈜루멘스바이오스 | Self | 135-81-19745 | Convertible bonds | 6,000,000 | 폴라리스 |
투자조합 | 주식 및
경영권
양수도 계약 | 2026.11.06 | 2026.10.21~
2026.12.07 | 25.82 | 주1,2) |
| Total (number of shares, etc.) | 7,900,000 | Total (ratio) | 34.00 | - |

주1) ㈜루멘스바이오스는 상기와 같은 내용으로 ㈜폴라리스세원 및 폴라리스투자조합과 발행회사에 대한 주식, 전환사채 및 경영권 양수도 계약을 체결(2026.10.21)하고 변경합의서를 체결(2026.11.06)하였으며, 잔금지급 및 관련 절차의 이행을 통해 주식 및 전환사채의 양수를 완료할 예정임.주2)

1. 주식 및 전환사채권 인도 예정일 : 2026-12-07

2. 매매대금 : 57,275,000,000원 (보통주 13,775,000,000원, 전환사채 43,500,000,000원), 전액 현금 지급

- 계약금 : 11,455,000,000원 (26.10.21, 지급완료)

- 중도금 : 17,182,500,000원 (26.11.16)

- 잔 금 : 28,637,500,000원 (26.12.07)

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person㈜루멘스바이오스135-81-19745-----------
Specially Related Party-------------
-------------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
㈜루멘스바이오스135-81-197452026.11.06기타(+)Voting Shares1,900,00001,900,000--Note 1)
㈜루멘스바이오스135-81-197452026.11.06기타(+)Convertible bonds6,000,00006,000,000--Note 1)

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

주1) 당사는 2026-10-21 ㈜폴라리스세원이 소유한 ㈜폴라리스우노 보통주 및 폴라리스투자조합이 소유한 ㈜폴라리스우노 제4회 전환사채에 대하여 주식, 전환사채 및 경영권 양수도계약을 체결하였으며, 2026-11-06 변경합의서를 체결하여 거래종결일을 2026-12-07로, 매매대금 지급방법을 전액 현금 지급으로 변경하였습니다. 보유주식등의 수는 변동이 없으며, 잔금 지급일에 거래는 종결됩니다. 지급 내역은 다음과 같습니다.가) 계약금 : ₩11,455,000,000 (지급일 : 2026. 10. 21, 지급완료)나) 중도금 : ₩17,182,500,000 (지급일 : 2026. 11. 16)다) 잔 금 : ₩28,637,500,000 (지급일 : 2026. 12. 7)

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
㈜루멘스바이오스135-81-1974539,275,000,000-18,000,000,00057,275,000,000

※ 상기 자기자금은 총 매매대금 572.75억원 중 계약금 114.55억원(2026. 10. 21 지급완료), 중도금 171.825억원(2026. 11. 16 지급예정) 및 잔금 중 106.375억원(2026. 12. 7 지급예정)입니다.

※ 기타 180억원은 잔금 중 당사 제7회 무기명식 이권부 무보증 사모 전환사채 발행(2026. 11. 18 현금납입) 조달자금으로 지급하는 금액입니다(2026. 12. 7 지급예정)

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
㈜루멘스바이오스135-81-19745보유자금

ㅇ 기타의 경우

| Name | Date of birth or business registration no., etc. | Source and Formation of Acquisition Funds |
|---|---|---|
| ㈜루멘스바이오스 | 135-81-19745 | 당사 제7회 무기명식 이권부 무보증 사모 전환사채(권면총액 20,000,000,000원, 2026. 11. 18 현금납입) 발행 조달자금 중 18,000,000,000원 |
- 인수인: ㈜폴라리스세원 13,775,000,000원, 폴라리스투자조합 6,225,000,000원 |